rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Creative Medical Technology Holdings, Inc.

CELZ · Nasdaq

Health CareBiotechnologyNot moving yet

CELZ stood above a rising 150-day average in 3 of the last 52 weekly readings, and has been out of that trend for the last 48 weeks. It is 51.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 48
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
13 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 3 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7,773$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders13+2 on the quarter
New · exited5 · 3
Reported value$540K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Hudson Bay Capital Management LPnew · filed 14 Aug 2026135,170$196K+135,170
Anson Funds Management LPnew · filed 13 Aug 2026105,549$153K+105,549
ARMISTICE CAPITAL, LLCnew · filed 14 Aug 202642,000$61K+42,000
XTX Topco Ltdadded · filed 14 Aug 202626,559$39K+12,299+86.2%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202625,799$37K-12,491−32.6%
VANGUARD CAPITAL MANAGEMENT LLCunchanged · filed 13 Aug 202620,350$30K00.0%
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 20265,518$8,00100.0%
Tower Research Capital LLC (TRC)added · filed 11 Aug 20264,853$7,037+2,761+132.0%
Global Retirement Partners, LLCnew · filed 6 Aug 20264,118$5,971+4,118
UBS Group AGadded · filed 13 Aug 20262,061$2,989+2,060+206000.0%
30 Jun 2023 – 30 Jun 2026
81113Jun 23Mar 24Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Timothy Warbington Company insiderPresident & CEO · last 24 Sep 20269 · 7
Michael H. Finger Company insiderDirector · last 19 Feb 20253 · 2
Donald Dickerson Company insiderCFO & Sr. VP · last 9 Feb 20220 · 0
Thomas Ichim Company insiderDirector · last 22 Jul 20210 · 3
Amit Nilkanth Patel Company insiderDirector · last 15 Jul 20210 · 0
Creative Medical Health Inc. Company insider10% owner · last 8 Jan 20211 · 7
Timothy Herbst Company insider10% owner · last 2 Dec 20161 · 0
Steven L. White Company insiderPresident · last 18 May 20160 · 1

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202563.4%
Return on capital employedFY 2025 · to 31 Dec 2025-81.6%
Share count trendFY 2025 · to 20 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$7.2M

Analyst forecasts

No analyst forecasts yet.